161 related articles for article (PubMed ID: 29233822)
21. The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-gamma receptor 1 and has a dominant-negative effect on interferon-gamma signal transduction.
Okada S; Ishikawa N; Shirao K; Kawaguchi H; Tsumura M; Ohno Y; Yasunaga S; Ohtsubo M; Takihara Y; Kobayashi M
J Med Genet; 2007 Aug; 44(8):485-91. PubMed ID: 17513528
[TBL] [Abstract][Full Text] [Related]
22. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection.
Döffinger R; Jouanguy E; Dupuis S; Fondanèche MC; Stephan JL; Emile JF; Lamhamedi-Cherradi S; Altare F; Pallier A; Barcenas-Morales G; Meinl E; Krause C; Pestka S; Schreiber RD; Novelli F; Casanova JL
J Infect Dis; 2000 Jan; 181(1):379-84. PubMed ID: 10608793
[TBL] [Abstract][Full Text] [Related]
23. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection.
Döffinger R; Altare F; Casanova JL
Microbes Infect; 2000 Nov; 2(13):1553-7. PubMed ID: 11113374
[TBL] [Abstract][Full Text] [Related]
24. Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection.
Martin E; Triccas JA; Kamath AT; Winter N; Britton WJ
Clin Exp Immunol; 2001 Dec; 126(3):482-7. PubMed ID: 11737066
[TBL] [Abstract][Full Text] [Related]
25. [Genetic predisposition to infective diseases in humans. Mendelian predisposition to mycobacterial infections].
Casanova JL
Bull Acad Natl Med; 2000; 184(7):1409-15; discussion 1415-6. PubMed ID: 11261247
[TBL] [Abstract][Full Text] [Related]
26. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection.
Martin E; Kamath AT; Briscoe H; Britton WJ
Immunology; 2003 Jun; 109(2):308-14. PubMed ID: 12757627
[TBL] [Abstract][Full Text] [Related]
27. Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway.
Haake K; Neehus AL; Buchegger T; Kühnel MP; Blank P; Philipp F; Oleaga-Quintas C; Schulz A; Grimley M; Goethe R; Jonigk D; Kalinke U; Boisson-Dupuis S; Casanova JL; Bustamante J; Lachmann N
Cells; 2020 Feb; 9(2):. PubMed ID: 32093117
[TBL] [Abstract][Full Text] [Related]
28. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection.
Tang C; Yamada H; Shibata K; Muta H; Wajjwalku W; Podack ER; Yoshikai Y
J Immunol; 2008 Nov; 181(9):6316-27. PubMed ID: 18941223
[TBL] [Abstract][Full Text] [Related]
29. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.
Dorman SE; Holland SM
J Clin Invest; 1998 Jun; 101(11):2364-9. PubMed ID: 9616207
[TBL] [Abstract][Full Text] [Related]
30. IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database.
van de Vosse E; van Dissel JT
Hum Mutat; 2017 Oct; 38(10):1286-1296. PubMed ID: 28744922
[TBL] [Abstract][Full Text] [Related]
31. Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency.
Kilic SS; van Wengen A; de Paus RA; Celebi S; Meziane B; Hafizoglu D; van Dissel JT; van de Vosse E
J Infect; 2012 Dec; 65(6):568-72. PubMed ID: 22902943
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey.
Roesler J; Horwitz ME; Picard C; Bordigoni P; Davies G; Koscielniak E; Levin M; Veys P; Reuter U; Schulz A; Thiede C; Klingebiel T; Fischer A; Holland SM; Casanova JL; Friedrich W
J Pediatr; 2004 Dec; 145(6):806-12. PubMed ID: 15580206
[TBL] [Abstract][Full Text] [Related]
33. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J
Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462
[TBL] [Abstract][Full Text] [Related]
34. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
[TBL] [Abstract][Full Text] [Related]
35. Enhanced protection against fatal mycobacterial infection in SCID beige mice by reshaping innate immunity with IFN-gamma transgene.
Xing Z; Zganiacz A; Wang J; Sharma SK
J Immunol; 2001 Jul; 167(1):375-83. PubMed ID: 11418673
[TBL] [Abstract][Full Text] [Related]
36. [Mendelian predisposition to mycobacterial infections in humans].
Casanova JL
J Soc Biol; 2000; 194(1):25-8. PubMed ID: 11107546
[TBL] [Abstract][Full Text] [Related]
37. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity.
Holland SM
Immunol Res; 2007; 38(1-3):342-6. PubMed ID: 17917041
[TBL] [Abstract][Full Text] [Related]
38. Disseminated Mycobacterium avium complex infection in a child with partial dominant interferon gamma receptor 1 deficiency in India.
Sharma VK; Pai G; Deswarte C; Lodha R; Singh S; Kang LW; Yin CC; Casanova JL; Bustamante J; Kabra SK
J Clin Immunol; 2015 Jul; 35(5):459-62. PubMed ID: 26054576
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterium simiae infection in two unrelated patients with different forms of inherited IFN-γR2 deficiency.
Martínez-Barricarte R; Megged O; Stepensky P; Casimir P; Moncada-Velez M; Averbuch D; Assous MV; Abuzaitoun O; Kong XF; Pedergnana V; Deswarte C; Migaud M; Rose-John S; Itan Y; Boisson B; Belkadi A; Conti F; Abel L; Vogt G; Boisson-Dupuis S; Casanova JL; Bustamante J
J Clin Immunol; 2014 Nov; 34(8):904-9. PubMed ID: 25135595
[TBL] [Abstract][Full Text] [Related]
40. A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.
Oleaga-Quintas C; Deswarte C; Moncada-Vélez M; Metin A; Krishna Rao I; Kanık-Yüksek S; Nieto-Patlán A; Guérin A; Gülhan B; Murthy S; Özkaya-Parlakay A; Abel L; Martínez-Barricarte R; Pérez de Diego R; Boisson-Dupuis S; Kong XF; Casanova JL; Bustamante J
Hum Mol Genet; 2018 Nov; 27(22):3919-3935. PubMed ID: 31222290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
